Plasma 3‐ O ‐Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report

Movement Disorders Clinical Practice · Published 2026-08-03 · DOI 10.1002/mdc3.70761

Free full text

Authors (9)

Shohei Okusa, Kotaro Okada, Yoshihiro Nihei, Risano Sakai, Takeshi Akiyoshi, Tomonori Nukariya, Jin Nakahara, Hisakazu Ohtani, Morinobu Seki

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Okusa, S., Okada, K., Nihei, Y., et al. (2026). Plasma 3‐ O ‐Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70761

Related articles